The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression.
暂无分享,去创建一个
[1] E. Canalis,et al. Mechanisms of Glucocorticoid Action in Bone , 2002, Current osteoporosis reports.
[2] N. Davidson,et al. Role of DNA Methylation and Histone Acetylation in Steroid Receptor Expression in Breast Cancer , 2001, Journal of Mammary Gland Biology and Neoplasia.
[3] R. Schleimer,et al. Antiinflammatory steroids inhibit granulocyte/macrophage colony-stimulating factor production by human lung tissue , 1994, Lung.
[4] J. Hamilton,et al. Reduction of tumor necrosis factor α and interleukin-1β levels in human synovial tissue by interleukin-4 and glucocorticoid , 1992, Rheumatology International.
[5] J. Hickman,et al. Apoptosis induced by anticancer drugs , 1992, Cancer and Metastasis Reviews.
[6] Ming-Zong Lai,et al. Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential* , 2003, The Journal of Biological Chemistry.
[7] M. Nakane,et al. A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects. , 2003, Molecular endocrinology.
[8] H. Garside,et al. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735. , 2003, Molecular endocrinology.
[9] R. Kaptein,et al. Molecular dynamics studies of a molecular switch in the glucocorticoid receptor. , 2003, Journal of molecular biology.
[10] Jürgen R. Müller,et al. Lymphotoxin β Receptor Induces Sequential Activation of Distinct NF-κB Factors via Separate Signaling Pathways* , 2003, The Journal of Biological Chemistry.
[11] C. Rochette-Egly. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. , 2003, Cellular signalling.
[12] G. Haegeman,et al. Transcriptional activation of the NF‐κB p65 subunit by mitogen‐ and stress‐activated protein kinase‐1 (MSK1) , 2003, The EMBO journal.
[13] J. Cidlowski,et al. Molecular Determinants of Glucocorticoid Receptor Mobility in Living Cells: the Importance of Ligand Affinity , 2003, Molecular and Cellular Biology.
[14] J. Haddad,et al. Interleukin-10 and the regulation of mitogen-activated protein kinases: are these signalling modules targets for the anti-inflammatory action of this cytokine? , 2003, Cellular signalling.
[15] T. Vanden Berghe,et al. Disruption of HSP90 Function Reverts Tumor Necrosis Factor-induced Necrosis to Apoptosis* , 2003, The Journal of Biological Chemistry.
[16] S. Elmore,et al. Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines. , 2003, Journal of medicinal chemistry.
[17] K. Klempnauer,et al. Recruitment of p300 by C/EBPβ triggers phosphorylation of p300 and modulates coactivator activity , 2003, The EMBO journal.
[18] M. Shannon,et al. Changes in Chromatin Accessibility Across the GM-CSF Promoter upon T Cell Activation Are Dependent on Nuclear Factor κB Proteins , 2003, The Journal of experimental medicine.
[19] I. Adcock,et al. Steroid Responsiveness of Renal Epithelial Cells , 2003, The Journal of Biological Chemistry.
[20] L. Espinosa,et al. IκBα and p65 Regulate the Cytoplasmic Shuttling of Nuclear Corepressors: Cross-talk between Notch and NFκB Pathways , 2003 .
[21] P. Hulley,et al. Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. , 2003, Endocrinology.
[22] J. Buckingham,et al. Cytokines: regulation of the hypothalamo-pituitary-adrenocortical axis. , 2003, Current opinion in pharmacology.
[23] K. Belguise,et al. Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect. , 2003, Molecular endocrinology.
[24] B. Necela,et al. Crystallization of the human glucocorticoid receptor ligand binding domain: a step towards selective glucocorticoids. , 2003, Trends in pharmacological sciences.
[25] G. Chrousos,et al. Tumor Necrosis Factor α Receptor- and Fas-associated FLASH Inhibit Transcriptional Activity of the Glucocorticoid Receptor by Binding to and Interfering with Its Interaction with p160 Type Nuclear Receptor Coactivators* , 2003, The Journal of Biological Chemistry.
[26] S. Simons,et al. A second pathway for modulating glucocorticoid receptor transactivation properties , 2003, Molecular and Cellular Endocrinology.
[27] F. Sladek,et al. MAP kinase phosphorylation‐dependent activation of Elk‐1 leads to activation of the co‐activator p300 , 2003, The EMBO journal.
[28] A. Foussat,et al. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. , 2003, Blood.
[29] J. Yates,et al. A novel estrogen receptor α-associated protein, template-activating factor iβ, inhibits acetylation and transactivation , 2003 .
[30] John H. White,et al. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. , 2003, Molecular cell.
[31] F. Marincola,et al. The dual role of IL-10. , 2003, Trends in immunology.
[32] Raj Kumar,et al. Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions. , 2003, Molecular endocrinology.
[33] M. Nakane,et al. A nonsteroidal glucocorticoid receptor antagonist. , 2003, Molecular endocrinology.
[34] P. Scheurich,et al. Tumor necrosis factor signaling , 2003, Cell Death and Differentiation.
[35] W. Tissing,et al. Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia , 2003, Leukemia.
[36] S. Planey,et al. Role of apical caspases and glucocorticoid-regulated genes in glucocorticoid-induced apoptosis of pre-B leukemic cells. , 2003, Cancer research.
[37] E. Sternberg,et al. Neuroendocrine regulation of immunity. , 2003, Annual review of immunology.
[38] Yuanzheng He,et al. Modulation of Induction Properties of Glucocorticoid Receptor-Agonist and -Antagonist Complexes by Coactivators Involves Binding to Receptors but Is Independent of Ability of Coactivators to Augment Transactivation* , 2002, The Journal of Biological Chemistry.
[39] K. Yamamoto,et al. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[40] Jiahuai Han,et al. Inhibition of p38 MAPK by Glucocorticoids via Induction of MAPK Phosphatase-1 Enhances Nontypeable Haemophilus influenzae-induced Expression of Toll-like Receptor 2* , 2002, The Journal of Biological Chemistry.
[41] N. Sarvetnick,et al. Cytokines: promoters and dampeners of autoimmunity. , 2002, Current opinion in immunology.
[42] T. Hofmann,et al. The Promoter Context Determines Mutual Repression or Synergism between NF-κB and the Glucocorticoid Receptor , 2002, Biological chemistry.
[43] Lea Sistonen,et al. Multisite phosphorylation provides sophisticated regulation of transcription factors. , 2002, Trends in biochemical sciences.
[44] J. Cidlowski,et al. Molecular mechanisms of glucocorticoid action and resistance , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[45] I. Adcock,et al. Molecular interactions between glucocorticoids and long-acting β2-agonists , 2002 .
[46] R. Haché,et al. Attenuation of glucocorticoid signaling through targeted degradation of p300 via the 26S proteasome pathway. , 2002, Molecular endocrinology.
[47] D. Endy,et al. Decoding NF-κB Signaling , 2002, Science.
[48] D. Endy,et al. Signal transduction. Decoding NF-kappaB signaling. , 2002, Science.
[49] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[50] P. Ricciardi-Castagnoli,et al. Interpretation of the complexity of innate immune responses by functional genomics , 2002, Nature Reviews Immunology.
[51] J. Carlstedt-Duke,et al. Involvement of multidrug resistance proteins (MDR) in the modulation of glucocorticoid response , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[52] K. Schulze-Osthoff,et al. Critical role of nuclear factor‐κB and stress‐activated protein kinases in steroid unresponsiveness , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] O. Jänne,et al. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. , 2002, The Biochemical journal.
[54] Tak W. Mak,et al. NF-κB Signaling Many Roads Lead To Madrid , 2002, Cell.
[55] Dimitris Thanos,et al. Deciphering the Transcriptional Histone Acetylation Code for a Human Gene , 2002, Cell.
[56] B. Turner,et al. Cellular Memory and the Histone Code , 2002, Cell.
[57] D. Trouche,et al. Control of CBP co‐activating activity by arginine methylation , 2002, The EMBO journal.
[58] T. Burn,et al. Dexamethasone and tumor necrosis factor-alpha act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell types. , 2002, Endocrinology.
[59] K. Imai,et al. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. , 2002, Molecular endocrinology.
[60] Khusru Asadullah,et al. Mechanisms involved in the side effects of glucocorticoids. , 2002, Pharmacology & therapeutics.
[61] I. Verma,et al. NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.
[62] T. Mustelin,et al. Arginine Methylation of STAT1 Regulates Its Dephosphorylation by T Cell Protein Tyrosine Phosphatase* , 2002, The Journal of Biological Chemistry.
[63] Stuart L. Schreiber,et al. Active genes are tri-methylated at K4 of histone H3 , 2002, Nature.
[64] K. Luger. The tail does not always wag the dog , 2002, Nature Genetics.
[65] H. E. Marshall,et al. Nitrosative Stress-induced Apoptosis through Inhibition of NF-κB* , 2002, The Journal of Biological Chemistry.
[66] F. Ledo,et al. Ca2+‐dependent block of CREB–CBP transcription by repressor DREAM , 2002, The EMBO journal.
[67] W. V. Berghe,et al. Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit , 2002 .
[68] Gioacchino Natoli,et al. Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. , 2002, Genes & development.
[69] D. Michel,et al. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. , 2002, Endocrinology.
[70] G. Chrousos,et al. Increased glucocorticoid receptor Beta expression converts mouse hybridoma cells to a corticosteroid-insensitive phenotype. , 2002, American journal of respiratory cell and molecular biology.
[71] G. Johnson,et al. Signalling: Mixed-lineage kinase control of JNK and p38 MAPK pathways , 2002, Nature Reviews Molecular Cell Biology.
[72] Ann Richmond,et al. NF-κB, chemokine gene transcription and tumour growth , 2002, Nature Reviews Immunology.
[73] R. Morimoto. Dynamic Remodeling of Transcription Complexes by Molecular Chaperones , 2002, Cell.
[74] G. Hager,et al. Glucocorticoid Receptor Domain Requirements for Chromatin Remodeling and Transcriptional Activation of the Mouse Mammary Tumor Virus Promoter in Different Nucleoprotein Contexts* , 2002, The Journal of Biological Chemistry.
[75] R. Orlowski,et al. NF-?B as a therapeutic target in cancer , 2002 .
[76] B. Deroo,et al. Differential activation of the IκBα and mouse mammary tumor virus promoters by progesterone and glucocorticoid receptors , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[77] A. Greenleaf,et al. Hyperphosphorylated C-terminal Repeat Domain-associating Proteins in the Nuclear Proteome Link Transcription to DNA/Chromatin Modification and RNA Processing* , 2002, Molecular & Cellular Proteomics.
[78] J. Brewer,et al. Green Fluorescent Protein-Glucocorticoid Receptor Knockin Mice Reveal Dynamic Receptor Modulation During Thymocyte Development1 , 2002, The Journal of Immunology.
[79] A. Yoshimura,et al. Regulation of cytokine signaling and inflammation. , 2002, Cytokine & growth factor reviews.
[80] S. Greenfeder,et al. New asthma targets: recent clinical and preclinical advances. , 2002, Current opinion in chemical biology.
[81] C. Allis,et al. Involvement of Histone Methylation and Phosphorylation in Regulation of Transcription by Thyroid Hormone Receptor , 2002, Molecular and Cellular Biology.
[82] Rey-Huei Chen,et al. Molecular interpretation of ERK signal duration by immediate early gene products , 2002, Nature Cell Biology.
[83] S. Berger,et al. Trans-tail histone modifications: wedge or bridge? , 2002, Nature Structural Biology.
[84] M. Nakane,et al. trans-Activation and repression properties of the novel nonsteroid glucocorticoid receptor ligand 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four stereoisomers. , 2002, Molecular pharmacology.
[85] M. Cosma. Ordered recruitment: gene-specific mechanism of transcription activation. , 2002, Molecular cell.
[86] Xin Lu,et al. Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.
[87] J. Cidlowski,et al. The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. , 2002, Molecular endocrinology.
[88] J. Pfeilschifter,et al. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors. , 2002, Molecular endocrinology.
[89] S. Lomvardas,et al. Modifying Gene Expression Programs by Altering Core Promoter Chromatin Architecture , 2002, Cell.
[90] Simak Ali,et al. Phosphorylation of human estrogen receptor α at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera , 2002, Oncogene.
[91] D. Scott,et al. A Point Mutation of the AF2 Transactivation Domain of the Glucocorticoid Receptor Disrupts Its Interaction with Steroid Receptor Coactivator 1* , 2002, The Journal of Biological Chemistry.
[92] M. Garabedian,et al. Deciphering the Phosphorylation “Code” of the Glucocorticoid Receptor in Vivo * 210 , 2002, The Journal of Biological Chemistry.
[93] T. Willson,et al. Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition , 2002, Cell.
[94] G. Ghosh,et al. The κB DNA Sequence from the HIV Long Terminal Repeat Functions as an Allosteric Regulator of HIV Transcription* , 2002, The Journal of Biological Chemistry.
[95] J. Schölmerich,et al. Anti‐inflammatory cooperativity of corticosteroids and norepinephrine in rheumatoid arthritis synovial tissue in vivo and in vitro , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[96] D. DeFranco. Navigating steroid hormone receptors through the nuclear compartment. , 2002, Molecular endocrinology.
[97] D. Kenan,et al. Direct interactions between corepressors and coactivators permit the integration of nuclear receptor-mediated repression and activation. , 2002, Molecular endocrinology.
[98] A. Cato,et al. Rapid Actions of Steroid Receptors in Cellular Signaling Pathways , 2002, Science's STKE.
[99] K. Yamamoto,et al. Disassembly of Transcriptional Regulatory Complexes by Molecular Chaperones , 2002, Science.
[100] S. Kaul,et al. Structure/Activity Elements of the Multifunctional Protein, GMEB-1 , 2002, The Journal of Biological Chemistry.
[101] G. Piwien-Pilipuk,et al. Differences in nuclear retention characteristics of agonist-activated glucocorticoid receptor may determine specific responses. , 2002, Experimental cell research.
[102] J. Jacobs,et al. Glucocorticoids in Rheumatoid Arthritis , 2002, Annals of the New York Academy of Sciences.
[103] Yun-Bo Shi,et al. Chromatin Disruption and Histone Acetylation in Regulation of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat by Thyroid Hormone Receptor , 2002, Molecular and Cellular Biology.
[104] G. Neeck. Fifty Years of Experience with Cortisone Therapy in the Study and Treatment of Rheumatoid Arthritis , 2002, Annals of the New York Academy of Sciences.
[105] J. Cidlowski,et al. Phosphorylation status modulates Bcl‐2 function during glucocorticoid‐induced apoptosis in T lymphocytes , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[106] Xiaodong Cheng,et al. Synergy among Nuclear Receptor Coactivators: Selective Requirement for Protein Methyltransferase and Acetyltransferase Activities , 2002, Molecular and Cellular Biology.
[107] G. Chrousos,et al. Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity , 2002, Annals of the New York Academy of Sciences.
[108] K. Saag. Glucocorticoid use in rheumatoid arthritis , 2002, Current rheumatology reports.
[109] Jong Soon Kang,et al. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells. , 2002, Toxicology and applied pharmacology.
[110] E. B. Thompson. The impact of genomics and proteomics on endocrinology. , 2002, Endocrine reviews.
[111] M. Neurath,et al. The role of Th1/Th2 polarization in mucosal immunity , 2002, Nature Medicine.
[112] N. Krett,et al. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[113] S. Werner,et al. A role for endogenous glucocorticoids in wound repair , 2002, EMBO reports.
[114] D. DeFranco,et al. Proteasomal Inhibition Enhances Glucocorticoid Receptor Transactivation and Alters Its Subnuclear Trafficking , 2002, Molecular and Cellular Biology.
[115] K. Resing,et al. Phosphatase Inhibition Leads to Histone Deacetylases 1 and 2 Phosphorylation and Disruption of Corepressor Interactions* , 2002, The Journal of Biological Chemistry.
[116] M. Rao,et al. Interaction of PIMT with Transcriptional Coactivators CBP, p300, and PBP Differential Role in Transcriptional Regulation* , 2002, The Journal of Biological Chemistry.
[117] W. V. Berghe,et al. DNA Binding-Independent Induction of IκBα Gene Transcription by PPARα , 2002 .
[118] L. Neckers. Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[119] C. Libert,et al. HSP70 protects against TNF-induced lethal inflammatory shock. , 2002, Immunity.
[120] M. Karin,et al. AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.
[121] C. Thiemermann. Corticosteroids and cardioprotection , 2002, Nature Medicine.
[122] M. Moskowitz,et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase , 2002, Nature Medicine.
[123] L. Freedman,et al. Reciprocal Recruitment of DRIP/Mediator and p160 Coactivator Complexes in Vivo by Estrogen Receptor* , 2002, The Journal of Biological Chemistry.
[124] D. Littman,et al. Nuclear Hormone Receptors in T Lymphocytes , 2002, Cell.
[125] S. Kaul,et al. Ubc9 Is a Novel Modulator of the Induction Properties of Glucocorticoid Receptors* , 2002, The Journal of Biological Chemistry.
[126] K. Deisseroth,et al. Dynamic Multiphosphorylation Passwords for Activity-Dependent Gene Expression , 2002, Neuron.
[127] T. Maniatis,et al. An extensive network of coupling among gene expression machines , 2002, Nature.
[128] I. Adcock,et al. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. , 2002, The Journal of allergy and clinical immunology.
[129] L. Freedman,et al. A coactivator code for transcription. , 2002, Trends in biochemical sciences.
[130] Chang‐Deng Hu,et al. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. , 2002, Molecular cell.
[131] F. B. Davis,et al. Comparison of the mechanisms of nongenomic actions of thyroid hormone and steroid hormones , 2002, Journal of endocrinological investigation.
[132] Cem Elbi,et al. Protein dynamics in the nuclear compartment. , 2002, Current opinion in genetics & development.
[133] L. Neckers,et al. Hsp90 inhibitors as novel cancer chemotherapeutic agents. , 2002, Trends in molecular medicine.
[134] M. Karin,et al. Missing Pieces in the NF-κB Puzzle , 2002, Cell.
[135] Richard A Young,et al. Deciphering gene expression regulatory networks. , 2002, Current opinion in genetics & development.
[136] B. Katzenellenbogen,et al. Defining the "S" in SERMs , 2002, Science.
[137] Myles Brown,et al. Molecular Determinants for the Tissue Specificity of SERMs , 2002, Science.
[138] L. Espinosa,et al. p65-NFkappaB synergizes with Notch to activate transcription by triggering cytoplasmic translocation of the nuclear receptor corepressor N-CoR. , 2002, Journal of cell science.
[139] David G Spiller,et al. Multi-parameter analysis of the kinetics of NF-kappaB signalling and transcription in single living cells. , 2002, Journal of cell science.
[140] S. Ghosh,et al. The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1 , 2002 .
[141] D. Franchimont,et al. Positive Effects of Glucocorticoids on T Cell Function by Up-Regulation of IL-7 Receptor α1 , 2002, The Journal of Immunology.
[142] O. Hermanson,et al. Nuclear receptor coregulators: multiple modes of modification , 2002, Trends in Endocrinology & Metabolism.
[143] X. Li,et al. Transcriptional and post‐transcriptional mechanisms of glucocorticoid antiproliferative effects , 2002, Hematological oncology.
[144] K. Asadullah,et al. Dichotomy of glucocorticoid action in the immune system. , 2002, Trends in immunology.
[145] P. Srivastava. Roles of heat-shock proteins in innate and adaptive immunity , 2002, Nature Reviews Immunology.
[146] Michael Karin,et al. NF-κB at the crossroads of life and death , 2002, Nature Immunology.
[147] Y. Shang,et al. Formation of the androgen receptor transcription complex. , 2002, Molecular cell.
[148] Neil J. McKenna,et al. Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.
[149] E. R. Sánchez,et al. A New First Step in Activation of Steroid Receptors , 2002, The Journal of Biological Chemistry.
[150] M. Rosenfeld,et al. Biological roles and mechanistic actions of co-repressor complexes. , 2002, Journal of cell science.
[151] H. Miyaura,et al. Direct and Indirect Inhibition of Th1 Development by Progesterone and Glucocorticoids1 , 2002, The Journal of Immunology.
[152] D. Goeddel,et al. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. , 2002, Molecular cell.
[153] Simak Ali,et al. Endocrine-responsive breast cancer and strategies for combating resistance , 2002, Nature Reviews Cancer.
[154] S. L. Calzi,et al. Vanadate increases glucocorticoid receptor-mediated gene expression: a novel mechanism for potentiation of a steroid receptor , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[155] J. Iñiguez-Lluhí,et al. The Activated Glucocorticoid Receptor Modulates Presumptive Autoregulation of Ribosomal Protein S6 Protein Kinase, p70 S6K* , 2002, The Journal of Biological Chemistry.
[156] J. Saklatvala. Glucocorticoids: do we know how they work? , 2002, Arthritis Research & Therapy.
[157] W. Geissler,et al. Allosteric Effects of Dexamethasone and RU486 on Glucocorticoid Receptor-DNA Interactions* , 2002, The Journal of Biological Chemistry.
[158] W. Almawi,et al. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor , 2002, Journal of leukocyte biology.
[159] M. Cooper,et al. Prereceptor regulation of glucocorticoid action by 11β‐hydroxysteroid dehydrogenase: a novel determinant of cell proliferation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[160] D. Gilroy,et al. Different glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells , 2002, British journal of pharmacology.
[161] P. Workman,et al. HSP90 as a new therapeutic target for cancer therapy: the story unfolds , 2002, Expert opinion on biological therapy.
[162] M. Mathews,et al. The RNA Binding Protein Nuclear Factor 90 Functions as Both a Positive and Negative Regulator of Gene Expression in Mammalian Cells , 2002, Molecular and Cellular Biology.
[163] D. Franchimont,et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[164] G. Stark,et al. Distinct Roles of the IκB Kinase α and β Subunits in Liberating Nuclear Factor κB (NF-κB) from IκB and in Phosphorylating the p65 Subunit of NF-κB* , 2001, The Journal of Biological Chemistry.
[165] C. Kellendonk,et al. Analysis of glucocorticoid receptor function in the mouse by gene targeting. , 2002, Ernst Schering Research Foundation workshop.
[166] W. V. Berghe,et al. Induction and Repression of NF-κB-Driven Inflammatory Genes , 2002 .
[167] A. Hsueh,et al. Hormonal genomics : The impact of the human genome on endocrinology , 2002 .
[168] 東島 由一郎. NAK is an IκB kinase-activating kinase , 2002 .
[169] O. Kassel,et al. Mast cells as targets for glucocorticoids in the treatment of allergic disorders. , 2002, Ernst Schering Research Foundation workshop.
[170] H. Volk,et al. Immune monitoring of glucocorticoid therapy. , 2002, Ernst Schering Research Foundation workshop.
[171] D. Franchimont,et al. Glucocorticoid-inducible genes that regulate T-cell function. , 2002, Ernst Schering Research Foundation workshop.
[172] K. Asadullah,et al. SEGRAs: a novel class of anti-inflammatory compounds. , 2002, Ernst Schering Research Foundation workshop.
[173] G. Stark,et al. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. , 2002, The Journal of biological chemistry.
[174] K. Väänänen,et al. Bone effects of glucocorticoid therapy. , 2002, Ernst Schering Research Foundation workshop.
[175] S. Umland,et al. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. , 2002, Pulmonary pharmacology & therapeutics.
[176] J. Jacobs,et al. Glucocorticoids in rheumatoid arthritis: effects on erosions and bone. , 2002, Annals of the New York Academy of Sciences.
[177] P. Barnes. Glucocorticoids and asthma. , 2002, Ernst Schering Research Foundation workshop.
[178] Chen Dong,et al. MAP kinases in the immune response. , 2002, Annual review of immunology.
[179] P. Barnes. Cytokine modulators as novel therapies for asthma. , 2002, Annual review of pharmacology and toxicology.
[180] A. Wikström,et al. Cytosolic glucocorticoid receptor-interacting proteins. , 2002, Ernst Schering Research Foundation workshop.
[181] U. Egner. Structural analysis of the GR ligand-binding domain. , 2002, Ernst Schering Research Foundation workshop.
[182] B. Kacinski,et al. Hormonal regulation of the c‐fms proto‐oncogene in breast cancer cells is mediated by a composite glucocorticoid response element , 2002, Journal of cellular biochemistry.
[183] P. Herrlich,et al. The anti-inflammatory action of glucocorticoid hormones. , 2002, Ernst Schering Research Foundation workshop.
[184] A. Fisher,et al. Chromatin structure and gene regulation in the immune system. , 2002, Annual review of immunology.
[185] G. Hager. The dynamics of intranuclear movement and chromatin remodeling by the glucocorticoid receptor. , 2002, Ernst Schering Research Foundation workshop.
[186] T. Heinzel,et al. DNA-dependent cofactor selectivity of the glucocorticoid receptor. , 2002, Ernst Schering Research Foundation workshop.
[187] D. DeFranco. Functional implications of glucocorticoid receptor trafficking. , 2002, Ernst Schering Research Foundation workshop.
[188] U. Wahn. Special problems in glucocorticoid treatment in children. , 2002, Ernst Schering Research Foundation workshop.
[189] J. Cidlowski,et al. The glucocorticoid receptor beta-isoform: a perspective on its relevance in human health and disease. , 2002, Ernst Schering Research Foundation workshop.
[190] A. Muñoz,et al. Glucocorticoid receptor antagonism of AP-1 activity by inhibition of MAPK family. , 2002, Ernst Schering Research Foundation workshop.
[191] K. Asadullah,et al. Topical glucocorticoid therapy in dermatology. , 2002, Ernst Schering Research Foundation workshop.
[192] S. Saccani,et al. p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.
[193] Y. Ben-Neriah. Regulatory functions of ubiquitination in the immune system , 2002, Nature Immunology.
[194] K. Muegge. Preparing the target for the bullet , 2002, Nature Immunology.
[195] L. Mahadevan,et al. Transcription: MAPK-regulated transcription: a continuously variable gene switch? , 2002, Nature Reviews Molecular Cell Biology.
[196] R. Flavell,et al. Transforming growth factor-β in T-cell biology , 2002, Nature Reviews Immunology.
[197] C. Distelhorst. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis , 2002, Cell Death and Differentiation.
[198] D. Corry. Emerging immune targets for the therapy of allergic asthma , 2002, Nature Reviews Drug Discovery.
[199] Peter Lipsky,et al. Cytokines and autoimmunity , 2002, Nature Reviews Immunology.
[200] Guy Perrière,et al. NUREBASE: database of nuclear hormone receptors , 2002, Nucleic Acids Res..
[201] A. Hsueh,et al. Hormonal genomics. , 2002, Endocrine reviews.
[202] N. McKenna,et al. 0013-7227/02/$15.00/0 Endocrinology 143(7):2461–2465 Printed in U.S.A. Copyright © 2002 by The Endocrine Society Minireview: Nuclear Receptor Coactivators—An Update , 2022 .
[203] D. Reinberg,et al. Switching Partners in a Regulatory Tango , 2001, Science.
[204] O. Kassel,et al. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP‐1 , 2001, The EMBO journal.
[205] P. Herrlich,et al. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor , 2001, The EMBO journal.
[206] Y. Makino,et al. Functional Modulation of the Glucocorticoid Receptor and Suppression of NF-κB-dependent Transcription by Ursodeoxycholic Acid* , 2001, The Journal of Biological Chemistry.
[207] A. Verdel,et al. Mechanism for Nucleocytoplasmic Shuttling of Histone Deacetylase 7* , 2001, The Journal of Biological Chemistry.
[208] C. Allis,et al. Hormone-dependent, CARM1-directed, arginine-specific methylation of histone H3 on a steroid-regulated promoter , 2001, Current Biology.
[209] Stephanie Birkey Reffey,et al. SNIP1 Inhibits NF-κB Signaling by Competing for Its Binding to the C/H1 Domain of CBP/p300 Transcriptional Co-activators* , 2001, The Journal of Biological Chemistry.
[210] R. Ye. Regulation of nuclear factor κB activation by G‐protein‐coupled receptors , 2001, Journal of leukocyte biology.
[211] T. Lawrence,et al. Possible new role for NF-κB in the resolution of inflammation , 2001, Nature Medicine.
[212] J. Cidlowski,et al. Proteasome-mediated Glucocorticoid Receptor Degradation Restricts Transcriptional Signaling by Glucocorticoids* , 2001, The Journal of Biological Chemistry.
[213] Tamás Kiss,et al. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes , 2001, Nature.
[214] M. Karin,et al. Inhibition of JNK activation through NF-κB target genes , 2001, Nature.
[215] Qiang Zhou,et al. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription , 2001, Nature.
[216] C. Allis,et al. Gene regulation: Code of silence , 2001, Nature.
[217] P. Cohen,et al. Regulation and Physiological Roles of Serum- and Glucocorticoid-Induced Protein Kinase Isoforms , 2001, Science's STKE.
[218] R. Gaynor,et al. Regulation of β-Catenin Function by the IκB Kinases* , 2001, The Journal of Biological Chemistry.
[219] Marc Montminy,et al. A Transcriptional Switch Mediated by Cofactor Methylation , 2001, Science.
[220] B. Deroo,et al. Glucocorticoid Receptor Activation of the IκBα Promoter within Chromatin , 2001 .
[221] A. Cato,et al. BAG-1 family of cochaperones in the modulation of nuclear receptor action , 2001, The Journal of Steroid Biochemistry and Molecular Biology.
[222] J. Haller,et al. Non-genomic effects of glucocorticoids in the neural system Evidence, mechanisms and implications , 2001, Progress in Neurobiology.
[223] I. Adcock,et al. Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation. , 2001, European journal of pharmacology.
[224] C. Glass,et al. Coregulator Codes of Transcriptional Regulation by Nuclear Receptors* , 2001, The Journal of Biological Chemistry.
[225] J. Herman,et al. Synergistic activation of functional estrogen receptor (ER)-α by DNA methyltransferase and histone deacetylase inhibition in human ER-α-negative breast cancer cells , 2001 .
[226] S. Smale,et al. Core promoters: active contributors to combinatorial gene regulation. , 2001, Genes & development.
[227] V. Laudet,et al. How many nuclear hormone receptors are there in the human genome? , 2001, Trends in genetics : TIG.
[228] A. Harel-Bellan,et al. Mitogen-Regulated RSK2-CBP Interaction Controls Their Kinase and Acetylase Activities , 2001, Molecular and Cellular Biology.
[229] Sandy D. Westerheide,et al. The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene Expression , 2001, Molecular and Cellular Biology.
[230] L. Deterding,et al. Hormone-mediated Dephosphorylation of Specific Histone H1 Isoforms* , 2001, The Journal of Biological Chemistry.
[231] J. Karn,et al. Activation of Human Immunodeficiency Virus Transcription in T Cells Revisited: NF-κB p65 Stimulates Transcriptional Elongation , 2001, Journal of Virology.
[232] T. Maniatis,et al. NF-(cid:1) B signaling pathways in mammalian and insect innate immunity , 2001 .
[233] A. Means,et al. The Modular Nature of Histone Deacetylase HDAC4 Confers Phosphorylation-dependent Intracellular Trafficking* , 2001, The Journal of Biological Chemistry.
[234] M. Montminy,et al. Distinct effects of cAMP and mitogenic signals on CREB-binding protein recruitment impart specificity to target gene activation via CREB , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[235] M. Karin,et al. Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.
[236] R. Goodman,et al. Acetylation of Nuclear Hormone Receptor-Interacting Protein RIP140 Regulates Binding of the Transcriptional Corepressor CtBP , 2001, Molecular and Cellular Biology.
[237] K. Horwitz,et al. Transcriptional Hyperactivity of Human Progesterone Receptors Is Coupled to Their Ligand-Dependent Down-Regulation by Mitogen-Activated Protein Kinase-Dependent Phosphorylation of Serine 294 , 2001, Molecular and Cellular Biology.
[238] Eric Verdin,et al. Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.
[239] Michael Karin,et al. Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.
[240] I. Adcock,et al. p65-activated Histone Acetyltransferase Activity Is Repressed by Glucocorticoids , 2001, The Journal of Biological Chemistry.
[241] C. Allis,et al. Translating the Histone Code , 2001, Science.
[242] S. Lomvardas,et al. Coordination of a transcriptional switch by HMGI(Y) acetylation. , 2001, Science.
[243] J. Ashwell,et al. Inhibition of AP-1 by the Glucocorticoid-inducible Protein GILZ* , 2001, The Journal of Biological Chemistry.
[244] B. Peterlin,et al. NF-κB Binds P-TEFb to Stimulate Transcriptional Elongation by RNA Polymerase II , 2001 .
[245] P. Gass,et al. Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: Models for depression and anxiety? , 2001, Physiology & Behavior.
[246] T. Archer,et al. Histone H1 Phosphorylation by Cdk2 Selectively Modulates Mouse Mammary Tumor Virus Transcription through Chromatin Remodeling , 2001, Molecular and Cellular Biology.
[247] G. Caramori,et al. Cross‐talk between pro‐inflammatory transcription factors and glucocorticoids , 2001, Immunology and cell biology.
[248] Marc Montminy,et al. Transcriptional regulation by the phosphorylation-dependent factor CREB , 2001, Nature Reviews Molecular Cell Biology.
[249] C. Riccardi,et al. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. , 2001, Blood.
[250] E. R. Sánchez,et al. Inhibition of heat shock transcription factor by GR. , 2001, Molecular endocrinology.
[251] H. Saito,et al. PPAR a and GR Differentially DownRegulate the Expression of Nuclear Factor-k B-Responsive Genes in Vascular Endothelial Cells , 2001 .
[252] D. Kressler,et al. Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[253] H. Beere. Stressed to Death: Regulation of Apoptotic Signaling Pathways by the Heat Shock Proteins , 2001, Science's STKE.
[254] A. Seto,et al. c-Jun Binds the N Terminus of Human TAFII250 to Derepress RNA Polymerase II Transcription in Vitro * , 2001, The Journal of Biological Chemistry.
[255] A. Bert,et al. A NF-κB/Sp1 Region Is Essential for Chromatin Remodeling and Correct Transcription of a Human Granulocyte- Macrophage Colony-Stimulating Factor Transgene , 2001, The Journal of Immunology.
[256] J. Cidlowski,et al. Molecular identification and characterization of a and b forms of the glucocorticoid receptor. , 2001, Molecular endocrinology.
[257] S. Akinaga,et al. Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[258] M. Kawata,et al. Dynamic changes in subcellular localization of mineralocorticoid receptor in living cells: in comparison with glucocorticoid receptor using dual-color labeling with green fluorescent protein spectral variants. , 2001, Molecular endocrinology.
[259] Brian D. Strahl,et al. Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1 , 2001, Current Biology.
[260] S. Saccani,et al. Two Waves of Nuclear Factor κb Recruitment to Target Promoters , 2001, The Journal of experimental medicine.
[261] M. Karin,et al. AP-1--glucocorticoid receptor crosstalk taken to a higher level. , 2001, The Journal of endocrinology.
[262] C. Watson,et al. Membrane estrogen and glucocorticoid receptors--implications for hormonal control of immune function and autoimmunity. , 2001, International immunopharmacology.
[263] L. Freedman,et al. Mediator complexes and transcription. , 2001, Current opinion in cell biology.
[264] C. Allis,et al. Histone methylation versus histone acetylation: new insights into epigenetic regulation. , 2001, Current opinion in cell biology.
[265] R. Marmorstein. Protein modules that manipulate histone tails for chromatin regulation , 2001, Nature Reviews Molecular Cell Biology.
[266] E. Sternberg,et al. Neuroendocrine regulation of autoimmune/inflammatory disease. , 2001, The Journal of endocrinology.
[267] Sergey Belikov,et al. Hormone‐induced nucleosome positioning in the MMTV promoter is reversible , 2001, The EMBO journal.
[268] J. Cidlowski,et al. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: A mechanism for the generation of glucocorticoid resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[269] B. Katzenellenbogen,et al. Direct Acetylation of the Estrogen Receptor α Hinge Region by p300 Regulates Transactivation and Hormone Sensitivity* , 2001, The Journal of Biological Chemistry.
[270] C. Allis,et al. Methylation of Histone H4 at Arginine 3 Facilitating Transcriptional Activation by Nuclear Hormone Receptor , 2001, Science.
[271] Suzanne D. Conzen,et al. Glucocorticoid Receptor-mediated Protection from Apoptosis Is Associated with Induction of the Serine/Threonine Survival Kinase Gene, sgk-1 * , 2001, The Journal of Biological Chemistry.
[272] R. Evans,et al. Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. , 2001, Genes & development.
[273] W. Tansey,et al. Transcriptional activation: risky business. , 2001, Genes & development.
[274] K. Yamamoto,et al. Continuous recycling: a mechanism for modulatory signal transduction. , 2001, Trends in biochemical sciences.
[275] P. Herrlich. Cross-talk between glucocorticoid receptor and AP-1 , 2001, Oncogene.
[276] T. Grange,et al. Glucocorticoid‐induced DNA demethylation and gene memory during development , 2001, The EMBO journal.
[277] D. Kioussis,et al. Glucocorticoids Attenuate T Cell Receptor Signaling , 2001, The Journal of experimental medicine.
[278] F. Holsboer,et al. β2-adrenergic receptors potentiate glucocorticoid receptor transactivation via G protein βγ-subunits and the phosphoinositide 3-kinase pathway. , 2001 .
[279] J. Gustafsson,et al. Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140. , 2001, Molecular endocrinology.
[280] I. Adcock,et al. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[281] M. Cobb,et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.
[282] Chawnshang Chang,et al. Androgen Receptor Interacts with the Positive Elongation Factor P-TEFb and Enhances the Efficiency of Transcriptional Elongation* , 2001, The Journal of Biological Chemistry.
[283] S. Kato,et al. Retracted: A subfamily of RNA‐binding DEAD‐box proteins acts as an estrogen receptor α coactivator through the N‐terminal activation domain (AF‐1) with an RNA coactivator, SRA , 2001 .
[284] Wei Zhu,et al. Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription , 2001, Cell.
[285] G. Chrousos,et al. High Constitutive Glucocorticoid Receptor β in Human Neutrophils Enables Them to Reduce Their Spontaneous Rate of Cell Death in Response to Corticosteroids , 2001, The Journal of experimental medicine.
[286] M. Schmitz,et al. I?B-independent control of NF-?B activity by modulatory phosphorylations , 2001 .
[287] M. Lazar,et al. Determinants of CoRNR-Dependent Repression Complex Assembly on Nuclear Hormone Receptors , 2001, Molecular and Cellular Biology.
[288] D. Bernhard,et al. Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid‐induced apoptosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[289] S. S. Koh,et al. Interaction of a transcriptional repressor with the RNA polymerase II holoenzyme plays a crucial role in repression , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[290] K. Das. c-Jun NH2-terminal Kinase-mediated Redox-dependent Degradation of IκB , 2001, The Journal of Biological Chemistry.
[291] H. E. Marshall,et al. Inhibition of NF-kappa B by S-nitrosylation. , 2001, Biochemistry.
[292] Gratien G. Prefontaine,et al. Glucocorticoid Receptor Homodimers and Glucocorticoid-Mineralocorticoid Receptor Heterodimers Form in the Cytoplasm through Alternative Dimerization Interfaces , 2001, Molecular and Cellular Biology.
[293] C. Battram,et al. Therapeutic Benefit of a Dissociated Glucocorticoid and the Relevance of In Vitro Separation of Transrepression from Transactivation Activity , 2001, The Journal of Immunology.
[294] W. V. Berghe,et al. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. , 2001, Molecular endocrinology.
[295] J. Turkson,et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. , 2001, The Journal of clinical investigation.
[296] J. Saklatvala,et al. Dexamethasone Destabilizes Cyclooxygenase 2 mRNA by Inhibiting Mitogen-Activated Protein Kinase p38 , 2001, Molecular and Cellular Biology.
[297] Brian A. Hemmings,et al. Protein Kinase SGK Mediates Survival Signals by Phosphorylating the Forkhead Transcription Factor FKHRL1 (FOXO3a) , 2001, Molecular and Cellular Biology.
[298] M. Quinkler,et al. Clinical implications of glucocorticoid metabolism by 11beta-hydroxysteroid dehydrogenases in target tissues. , 2001, European journal of endocrinology.
[299] Y. Tao,et al. Mapping of Glucocorticoid Receptor DNA Binding Domain Surfaces Contributing to Transrepression of NF-κB and Induction of Apoptosis* , 2001, The Journal of Biological Chemistry.
[300] M. Stallcup,et al. Synergistic Enhancement of Nuclear Receptor Function by p160 Coactivators and Two Coactivators with Protein Methyltransferase Activities* , 2001, The Journal of Biological Chemistry.
[301] P. McNamara,et al. Regulation of Histone Acetylation and Transcription by INHAT, a Human Cellular Complex Containing the Set Oncoprotein , 2001, Cell.
[302] J. Mariani,et al. The orphan nuclear receptor RORα is a negative regulator of the inflammatory response , 2001 .
[303] D. Trouche,et al. Physical association between the histone acetyl transferase CBP and a histone methyl transferase , 2001, EMBO reports.
[304] J. Cobb,et al. The Heat Shock Paradox: Does Nf-b Determine Cell Fate? Stress Response Interactions Are Implicated in Cellular and Organ Dysfunction , 2001 .
[305] R. Tjian,et al. Transcriptional coactivator complexes. , 2001, Annual review of biochemistry.
[306] S. Lamas,et al. Nitric oxide as a regulator of gene expression: Studies with the transcription factor proteins cJun and p50 , 2001, BioFactors.
[307] X. Xu,et al. PPARalpha and GR differentially down-regulate the expression of nuclear factor-kappaB-responsive genes in vascular endothelial cells. , 2001, Endocrinology.
[308] C. Allis,et al. Histone acetyltransferases. , 2001, Annual review of biochemistry.
[309] D. Reinberg,et al. Transcription. Switching partners in a regulatory tango. , 2001, Science.
[310] S. Kato. Estrogen receptor-mediated cross-talk with growth factor signaling pathways , 2001, Breast cancer.
[311] A. Wolffe,et al. A necessary good: nuclear hormone receptors and their chromatin templates. , 2001, Molecular endocrinology.
[312] M. Karin,et al. Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway. , 2001, Molecular endocrinology.
[313] P. Tak,et al. NF-κB: a key role in inflammatory diseases , 2001 .
[314] A. Hoffmann,et al. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event , 2001, Nature Immunology.
[315] A. Baldwin. Series Introduction: The transcription factor NF-κB and human disease , 2001 .
[316] T. Maniatis,et al. NF-B signaling pathways in mammalian and insect innate immunity , 2001 .
[317] Y. Wan,et al. Separable features of the ligand-binding domain determine the differential subcellular localization and ligand-binding specificity of glucocorticoid receptor and progesterone receptor. , 2001, Molecular endocrinology.
[318] S. Rusconi,et al. Serine / threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling , 2001, BMC Cell Biology.
[319] Shih-Ming Huang,et al. Synergistic, p160 Coactivator-dependent Enhancement of Estrogen Receptor Function by CARM1 and p300* , 2000, The Journal of Biological Chemistry.
[320] J. Palvimo,et al. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[321] A. Wikström,et al. Glucocorticoid Receptor Interaction with 14-3-3 and Raf-1, a Proposed Mechanism for Cross-talk of Two Signal Transduction Pathways* , 2000, The Journal of Biological Chemistry.
[322] Myles Brown,et al. Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.
[323] D. Sharma,et al. Temporal formation of distinct thyroid hormone receptor coactivator complexes in HeLa cells. , 2000, Molecular endocrinology.
[324] J. Reed,et al. Hsp70–RAP46 interaction in downregulation of DNA binding by glucocorticoid receptor , 2000, The EMBO journal.
[325] R. Borski. Nongenomic Membrane Actions of Glucocorticoids in Vertebrates , 2000, Trends in Endocrinology & Metabolism.
[326] L. Cohn,et al. Altering the Th1/Th2 balance as a therapeutic strategy in asthmatic diseases. , 2000, Current opinion in investigational drugs.
[327] J. Whitsett,et al. Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[328] G. Hager,et al. Trafficking of nuclear receptors in living cells , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[329] D. McDonnell,et al. Development of peptide antagonists that target estrogen receptor–cofactor interactions , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[330] Neil J McKenna,et al. From ligand to response: generating diversity in nuclear receptor coregulator function , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[331] B. Staels,et al. Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators* , 2000, The Journal of Biological Chemistry.
[332] J. Vonesch,et al. Negative cross‐talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells , 2000, The EMBO journal.
[333] H. Jörnvall,et al. Type 1 11β-Hydroxysteroid Dehydrogenase Mediates Glucocorticoid Activation and Insulin Release in Pancreatic Islets* , 2000, The Journal of Biological Chemistry.
[334] Dimitris Thanos,et al. Ordered Recruitment of Chromatin Modifying and General Transcription Factors to the IFN-β Promoter , 2000, Cell.
[335] G. Crabtree,et al. Transcription: Regulation of the regulators , 2000, Nature.
[336] B. Vargaftig,et al. Do glucocorticoids enhance eosinopoiesis? , 2000, Trends in pharmacological sciences.
[337] Dirk Schübeler,et al. Nuclear compartmentalization and gene activity , 2000, Nature Reviews Molecular Cell Biology.
[338] R. Evans,et al. Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[339] S. Westerheide,et al. Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II* , 2000, The Journal of Biological Chemistry.
[340] S. Schoonbroodt,et al. Oxidative stress interference with the nuclear factor- κB activation pathways , 2000 .
[341] W. V. Berghe,et al. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. , 2000, Biochemical pharmacology.
[342] R. Tjian,et al. Orchestrated response: a symphony of transcription factors for gene control. , 2000, Genes & development.
[343] C. Allis,et al. Signaling to Chromatin through Histone Modifications , 2000, Cell.
[344] R. Davis,et al. Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.
[345] P. Quail,et al. HFR1 encodes an atypical bHLH protein that acts in phytochrome A signal transduction. , 2000, Genes & development.
[346] H. E. Marshall,et al. Nitrosation and oxidation in the regulation of gene expression , 2000, The FASEB Journal.
[347] K. Senger,et al. Gene repression by coactivator repulsion. , 2000, Molecular cell.
[348] K. Schulze-Osthoff,et al. Molecular mechanisms of glucocorticoid resistance. , 2000, Gastroenterology.
[349] E. Cho,et al. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. , 2000, Genes & development.
[350] R. Morimoto,et al. The Chaperone Function of hsp70 Is Required for Protection against Stress-Induced Apoptosis , 2000, Molecular and Cellular Biology.
[351] L. Burke,et al. Co‐repressors 2000 , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[352] Steven A. Brown,et al. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. , 2000, Science.
[353] Danny Reinberg,et al. RNA polymerase II elongation through chromatin , 2000, Nature.
[354] K. Ley,et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase , 2000, Nature.
[355] D. Zink,et al. Chromodomains are protein–RNA interaction modules , 2000, Nature.
[356] W. Miller,et al. Ligand-inducible interaction of the DRIP/TRAP coactivator complex with retinoid receptors in retinoic acid–sensitive and –resistant acute promyelocytic leukemia cells , 2000 .
[357] K. Yamamoto,et al. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. , 2000, Genes & development.
[358] X. Hua,et al. Act1, an NF-κB-activating protein , 2000 .
[359] A. Leonardi,et al. CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[360] A. Muñoz,et al. Glucocorticoids Antagonize Ap-1 by Inhibiting the Activation/Phosphorylation of Jnk without Affecting Its Subcellular Distribution , 2000, The Journal of cell biology.
[361] N. Perkins. The Rel/NF-κB family: friend and foe , 2000 .
[362] W. V. Berghe,et al. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors , 2000, Journal of Neuroimmunology.
[363] I. Adcock,et al. Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 , 2000, Molecular and Cellular Biology.
[364] C. Lyttle,et al. The Role of CBP in Estrogen Receptor Cross-Talk with Nuclear Factor-κB in HepG2 Cells. , 2000, Endocrinology.
[365] G. Hager,et al. Structure and Dynamic Properties of a Glucocorticoid Receptor-Induced Chromatin Transition , 2000, Molecular and Cellular Biology.
[366] J. T. Kadonaga,et al. Exploring the transcription-chromatin interface. , 2000, Genes & development.
[367] L. Ivashkiv,et al. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[368] J. Cidlowski,et al. CBP (CREB Binding Protein) Integrates NF-κB (Nuclear Factor-κB) and Glucocorticoid Receptor Physical Interactions and Antagonism , 2000 .
[369] J. Gustafsson,et al. Recruitment of chromatin remodelling factors during gene activation via the glucocorticoid receptor N-terminal domain. , 2000, Biochemical Society transactions.
[370] P. Csermely,et al. Steroid Receptor and Molecular Chaperone Encounters in the Nucleus , 2000, Science's STKE.
[371] P. Chi,et al. Glucocorticoid-mediated Destabilization of Cyclin D3 mRNA Involves RNA-Protein Interactions in the 3′-Untranslated Region of the mRNA* , 2000, The Journal of Biological Chemistry.
[372] A. Israël,et al. Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. , 2000, Genes & development.
[373] J. Gustafsson,et al. Glucocorticoid Effects on NF-κB Binding in the Transcription of the ICAM-1 Gene☆ , 2000 .
[374] V. Ogryzko,et al. p300 and p300/cAMP-response Element-binding Protein-associated Factor Acetylate the Androgen Receptor at Sites Governing Hormone-dependent Transactivation* , 2000, The Journal of Biological Chemistry.
[375] D. F. Smith,et al. Molecular chaperone interactions with steroid receptors: an update. , 2000, Molecular endocrinology.
[376] M. Brandi,et al. Corticosteroid-induced osteoporosis: pathogenesis and prevention. , 2000, Clinical and experimental rheumatology.
[377] D. Moras,et al. Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity. , 2000, Molecular endocrinology.
[378] S. Kaul,et al. Properties of the glucocorticoid modulatory element binding proteins GMEB-1 and -2: potential new modifiers of glucocorticoid receptor transactivation and members of the family of KDWK proteins. , 2000, Molecular endocrinology.
[379] G. Hunninghake,et al. A constitutive active MEK --> ERK pathway negatively regulates NF-kappa B-dependent gene expression by modulating TATA-binding protein phosphorylation. , 2000, The Journal of biological chemistry.
[380] W. Mitch,et al. Glucocorticoids Induce Proteasome C3 Subunit Expression in L6 Muscle Cells by Opposing the Suppression of Its Transcription by NF-κB* , 2000, The Journal of Biological Chemistry.
[381] K. Horwitz,et al. The Mouse Mammary Tumor Virus Promoter Adopts Distinct Chromatin Structures in Human Breast Cancer Cells with and without Glucocorticoid Receptor* , 2000, The Journal of Biological Chemistry.
[382] K. Yamamoto,et al. Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[383] J. Manley,et al. RNA polymerase II and the integration of nuclear events. , 2000, Genes & development.
[384] Jiahuai Han,et al. Regulation of TNF Expression by Multiple Mitogen-Activated Protein Kinase Pathways1 , 2000, The Journal of Immunology.
[385] M. Tomic-Canic,et al. Novel Mechanism of Steroid Action in Skin through Glucocorticoid Receptor Monomers , 2000, Molecular and Cellular Biology.
[386] F. Wondisford,et al. The nuclear corepressors recognize distinct nuclear receptor complexes. , 2000, Molecular endocrinology.
[387] Dominique Thomas,et al. Inducible NF-κB Activation Is Permitted by Simultaneous Degradation of Nuclear IκBα* , 2000, The Journal of Biological Chemistry.
[388] I. Hansen,et al. Localization of glucocorticoid hormone receptors in mitochondria of human cells. , 2000, European journal of cell biology.
[389] T. Ashida,et al. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. , 2000, Gastroenterology.
[390] W. MacNee,et al. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. , 2000, Free radical biology & medicine.
[391] S. Plisov,et al. Ability of the glucocorticoid modulatory element to modify glucocorticoid receptor transactivation indicates parallel pathways for the expression of glucocorticoid modulatory element and glucocorticoid response element activities , 2000, Molecular and Cellular Endocrinology.
[392] F. Claessens,et al. Differences in DNA Binding Characteristics of the Androgen and Glucocorticoid Receptors Can Determine Hormone-specific Responses* , 2000, The Journal of Biological Chemistry.
[393] J. Parvin,et al. Binding of Liganded Vitamin D Receptor to the Vitamin D Receptor Interacting Protein Coactivator Complex Induces Interaction with RNA Polymerase II Holoenzyme* , 2000, The Journal of Biological Chemistry.
[394] W. V. Berghe,et al. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[395] J. V. Falvo,et al. A stimulus-specific role for CREB-binding protein (CBP) in T cell receptor-activated tumor necrosis factor alpha gene expression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[396] A. Israël. The IKK complex: an integrator of all signals that activate NF-κB? , 2000 .
[397] M. Lazar,et al. The DRIP Complex and SRC-1/p160 Coactivators Share Similar Nuclear Receptor Binding Determinants but Constitute Functionally Distinct Complexes , 2000, Molecular and Cellular Biology.
[398] M. Meaney,et al. 5'-heterogeneity of glucocorticoid receptor messenger RNA is tissue specific: differential regulation of variant transcripts by early-life events. , 2000, Molecular endocrinology.
[399] D. Ann,et al. Oxidative Stress Disrupts Glucocorticoid Hormone-dependent Transcription of the Amiloride-sensitive Epithelial Sodium Channel α-Subunit in Lung Epithelial Cells through ERK-dependent and Thioredoxin-sensitive Pathways* , 2000, The Journal of Biological Chemistry.
[400] Tony Kouzarides,et al. Acetylation: a regulatory modification to rival phosphorylation? , 2000, The EMBO journal.
[401] T. Maniatis,et al. IKKε Is Part of a Novel PMA-Inducible IκB Kinase Complex , 2000 .
[402] M. Mayo,et al. Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB , 2000, Molecular and Cellular Biology.
[403] M. Handel,et al. Inhibition Of Transcription Factors By Anti‐Inflammatory And Anti‐Rheumatic Drugs: Can Variability In Response Be Overcome? , 2000, Clinical and experimental pharmacology & physiology.
[404] G. Almouzni,et al. Hormone activation induces nucleosome positioning in vivo , 2000, The EMBO journal.
[405] D. Robyr,et al. Nuclear hormone receptor coregulators in action: diversity for shared tasks. , 2000, Molecular endocrinology.
[406] M. Montminy,et al. The Phosphorylation Status of a Cyclic AMP-Responsive Activator Is Modulated via a Chromatin-Dependent Mechanism , 2000, Molecular and Cellular Biology.
[407] J. McNally,et al. The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. , 2000, Science.
[408] S. Ghosh,et al. A Subclass of Ras Proteins That Regulate the Degradation of IκB , 2000 .
[409] Michael Karin,et al. The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling , 2000 .
[410] P. Keeling,et al. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. , 2000, Gastroenterology.
[411] C. Lange,et al. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[412] V. Prima,et al. Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[413] C. Allis,et al. The language of covalent histone modifications , 2000, Nature.
[414] A. Zlotnik,et al. The biology of chemokines and their receptors. , 2000, Annual review of immunology.
[415] C. Glass,et al. Nuclear receptor coactivators. , 2000, Advances in pharmacology.
[416] J. Ashwell,et al. Glucocorticoids in T cell development and function*. , 2000, Annual review of immunology.
[417] J. Piette,et al. Oxidative stress interference with the nuclear factor-kappa B activation pathways. , 2000, Biochemical pharmacology.
[418] J. Piette,et al. Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1. , 2000, Biochemical pharmacology.
[419] R. Kingston,et al. HFR1 encodes an atypical bHLH protein that acts in phytochrome A signal transduction , 2000 .
[420] M. Karin,et al. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.
[421] D. DeFranco,et al. Nuclear matrix targeting of steroid receptors: specific signal sequences and acceptor proteins. , 2000, Critical reviews in eukaryotic gene expression.
[422] M. Mancini,et al. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. , 2000, Molecular endocrinology.
[423] B. O’Malley,et al. FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasome-dependent , 2000, Nature Cell Biology.
[424] P. Connell,et al. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins , 2000, Nature Cell Biology.
[425] S. Ikuyama,et al. Glucocorticoid-induced osteoporosis: pathogenesis and management , 2000, Journal of Bone and Mineral Metabolism.
[426] W. Miller,et al. Ligand-inducible interaction of the DRIP/TRAP coactivator complex with retinoid receptors in retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells. , 2000, Blood.
[427] K. H. Richter,et al. The DNA Binding-Independent Function of the Glucocorticoid Receptor Mediates Repression of Ap-1–Dependent Genes in Skin , 1999, The Journal of cell biology.
[428] R. Evans,et al. Mechanism of corepressor binding and release from nuclear hormone receptors. , 1999, Genes & development.
[429] C. Glass,et al. Molecular determinants of nuclear receptor-corepressor interaction. , 1999, Genes & development.
[430] G. Hager,et al. A Ligand Binding Domain Mutation in the Mouse Glucocorticoid Receptor Functionally Links Chromatin Remodeling and Transcription Initiation , 1999, Molecular and Cellular Biology.
[431] D. Baltimore,et al. NF‐κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK‐related kinase , 1999, The EMBO journal.
[432] S. Simons,et al. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. , 1999, Molecular endocrinology.
[433] L. Freedman. Multimeric Coactivator Complexes for Steroid/Nuclear Receptors , 1999, Trends in Endocrinology & Metabolism.
[434] S. Smale,et al. Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription. , 1999, Immunity.
[435] J. Haeggström,et al. 5-Lipoxygenase upregulation by dexamethasone in human mast cells. , 1999, Biochemical and biophysical research communications.
[436] R. Wisdom,et al. AP-1: one switch for many signals. , 1999, Experimental cell research.
[437] H. Pahl. Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.
[438] M. Karin. How NF-κB is activated: the role of the IκB kinase (IKK) complex , 1999, Oncogene.
[439] Yukio Nakamura,et al. Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts , 1999, Oncogene.
[440] B. Rayet,et al. Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.
[441] C. Kellendonk,et al. The glucocorticoid receptor is required for stress erythropoiesis. , 1999, Genes & development.
[442] M. Mayo,et al. Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding* , 1999, The Journal of Biological Chemistry.
[443] Frank J. Gonzalez,et al. Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1* , 1999, The Journal of Biological Chemistry.
[444] G. Haegeman,et al. The Nuclear Factor-κB Engages CBP/p300 and Histone Acetyltransferase Activity for Transcriptional Activation of the Interleukin-6 Gene Promoter* , 1999, The Journal of Biological Chemistry.
[445] F. Autschbach,et al. Cell specific effects of glucocorticoid treatment on the NF-κBp65/IκBα system in patients with Crohn’s disease , 1999 .
[446] A. Bamberger,et al. Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes. , 1999, The Journal of clinical endocrinology and metabolism.
[447] David M. Rothwarf,et al. The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus , 1999, Science's STKE.
[448] H. Sakurai,et al. IκB Kinases Phosphorylate NF-κB p65 Subunit on Serine 536 in the Transactivation Domain* , 1999, The Journal of Biological Chemistry.
[449] K. Knudtson,et al. The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). , 1999, The Journal of biological chemistry.
[450] T. Gelehrter,et al. Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[451] A. Muñoz,et al. Hormone‐activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells , 1999, FEBS letters.
[452] L. Freedman,et al. Nuclear receptor cofactors as chromatin remodelers. , 1999, Current opinion in genetics & development.
[453] M. Garabedian,et al. Differential regulation of glucocorticoid receptor transcriptional activation via AF‐1‐associated proteins , 1999, The EMBO journal.
[454] G. Haegeman,et al. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism. , 1999, Molecular pharmacology.
[455] R. Evans,et al. Regulation of Hormone-Induced Histone Hyperacetylation and Gene Activation via Acetylation of an Acetylase , 1999, Cell.
[456] C. Watson,et al. Association of the glucocorticoid receptor alternatively‐spliced transcript 1A with the presence of the high molecular weight membrane glucocorticoid receptor in mouse lymphoma cells , 1999, Journal of cellular biochemistry.
[457] A. Sousa,et al. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation. , 1999, The Journal of allergy and clinical immunology.
[458] M. J. Barratt,et al. The nucleosomal response associated with immediate‐early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG‐14 kinase , 1999, The EMBO journal.
[459] C. Watson,et al. Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor‐enriched S‐49 mouse lymphoma cells , 1999, Journal of cellular biochemistry.
[460] P. Grant,et al. Histone Acetyltransferase Complexes Can Mediate Transcriptional Activation by the Major Glucocorticoid Receptor Activation Domain , 1999, Molecular and Cellular Biology.
[461] O. Kretz,et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety , 1999, Nature Genetics.
[462] H. Kwon,et al. Identification by In Vivo Genomic Footprinting of a Transcriptional Switch Containing NF-κB and Sp1 That Regulates the IκBα Promoter , 1999, Molecular and Cellular Biology.
[463] C. Glass,et al. Transcriptional Activation by NF-κB Requires Multiple Coactivators , 1999, Molecular and Cellular Biology.
[464] M. Hagmann. How Chromatin Changes Its Shape , 1999, Science.
[465] R. Panettieri,et al. Dexamethasone Pathway That Is Only Partially Sensitive to B-dependent Signaling Κ Involves an Nf- Human Tracheal Smooth Muscle Cells Up-regulation of Icam-1 by Cytokines In , 2013 .
[466] E. Bourke,et al. Antiinflammatory Effects of Glucocorticoids in Brain Cells, Independent of NF-κB , 1999 .
[467] C. Allis,et al. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. , 1999, Science.
[468] M. Arsura,et al. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[469] Yogesh K. Dwivedi,et al. Glucocorticoids Stimulate Inflammatory 5‐Lipoxygenase Gene Expression and Protein Translocation in the Brain , 1999, Journal of neurochemistry.
[470] J. Cidlowski,et al. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. , 1999, Endocrine reviews.
[471] L. Vuillard,et al. A complex containing βTrCP recruits Ccd34 to catalyse ubiquitination of IκBα , 1999, FEBS letters.
[472] N. Dean,et al. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. , 1999, Biochemistry.
[473] M. Garabedian,et al. Distinct Glucocorticoid Receptor Transcriptional Regulatory Surfaces Mediate the Cytotoxic and Cytostatic Effects of Glucocorticoids , 1999, Molecular and Cellular Biology.
[474] A. Aguzzi,et al. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice , 1999, Nature Genetics.
[475] T. Deerinck,et al. The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.
[476] R. Beyaert. NF-κB as an emerging target in atopy , 1999 .
[477] R. Lanz,et al. Nuclear receptor coregulators: cellular and molecular biology. , 1999, Endocrine reviews.
[478] Christian Kaltschmidt,et al. Repression of NF-κB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators , 1999, Oncogene.
[479] T. Kouzarides,et al. Characterization of an E1A-CBP Interaction Defines a Novel Transcriptional Adapter Motif (TRAM) in CBP/p300 , 1999, Journal of Virology.
[480] M. Eggert,et al. Alien, a Highly Conserved Protein with Characteristics of a Corepressor for Members of the Nuclear Hormone Receptor Superfamily , 1999, Molecular and Cellular Biology.
[481] R. Tjian,et al. Composite co-activator ARC mediates chromatin-directed transcriptional activation , 1999, Nature.
[482] Paul Tempst,et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex , 1999, Nature.
[483] K. Umesono,et al. A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.
[484] S. Akira,et al. Limb and skin abnormalities in mice lacking IKKalpha. , 1999, Science.
[485] Neil J McKenna,et al. A Steroid Receptor Coactivator, SRA, Functions as an RNA and Is Present in an SRC-1 Complex , 1999, Cell.
[486] A. Manning,et al. Multiple signals converging on NF-κB , 1999 .
[487] V. Giguère,et al. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. , 1999, Molecular cell.
[488] Claus Scheidereit,et al. NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.
[489] I. Choi,et al. Glucocorticoids prevent NF‐κB activation by inhibiting the early release of platelet‐activating factor in response to lipopolysaccharide , 1999, European journal of immunology.
[490] C. Glass,et al. Factor-specific modulation of CREB-binding protein acetyltransferase activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[491] G. Trinchieri,et al. Retinoids Inhibit Interleukin-12 Production in Macrophages through Physical Associations of Retinoid X Receptor and NFκB* , 1999, The Journal of Biological Chemistry.
[492] R. Evans,et al. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[493] P. Scherle,et al. Kinase targets in inflammation , 1999 .
[494] T. Maniatis,et al. A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. , 1999, Genes & development.
[495] R. Seger,et al. The Cytoskeletal Network Controls c-Jun Expression and Glucocorticoid Receptor Transcriptional Activity in an Antagonistic and Cell-Type-Specific Manner , 1999, Molecular and Cellular Biology.
[496] M. Benito,et al. Glucocorticoid receptor down‐Regulates c‐jun amino terminal kinases induced by tumor necrosis factor α in fetal rat hepatocyte primary cultures , 1999, Hepatology.
[497] D. DeFranco,et al. Chromatin recycling of glucocorticoid receptors: implications for multiple roles of heat shock protein 90. , 1999, Molecular endocrinology.
[498] J. Qin,et al. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. , 1999, Molecular cell.
[499] F. Sackey,et al. Plasma membrane-resident glucocorticoid receptors in rodent lymphoma and human leukemia models , 1999, Steroids.
[500] Robert Tjian,et al. The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1 , 1999, Nature.
[501] D. Wallach,et al. Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis , 1999 .
[502] Zhijian J. Chen,et al. Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β-TrCP , 1999 .
[503] Suping Han,et al. Effects of Glucocorticoids and Cyclosporine on IL‐2 and IκBα mRNA Expression in Human Peripheral Blood Mononuclear Cells , 1999 .
[504] G. Piwien-Pilipuk,et al. Inhibition of glucocorticoid receptor binding by nitric oxide. , 1999, Molecular pharmacology.
[505] R. Haché,et al. Discrimination between NL1- and NL2-Mediated Nuclear Localization of the Glucocorticoid Receptor , 1999, Molecular and Cellular Biology.
[506] P. Baeuerle,et al. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[507] D. Green,et al. Regulation of Fas-Ligand Expression during Activation-induced Cell Death in T Lymphocytes via Nuclear Factor κB* , 1999, The Journal of Biological Chemistry.
[508] C. Watson,et al. Membrane-Initiated Steroid Actions and the Proteins that Mediate Them , 1999 .
[509] M. Gallo,et al. Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity* , 1999, The Journal of Biological Chemistry.
[510] Y. Makino,et al. Redox regulation of the glucocorticoid receptor. , 1998, Antioxidants & redox signaling.
[511] Y. Nasuhara,et al. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. , 1996, British journal of pharmacology.
[512] S. Bhattacharya,et al. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. , 1999, Genes & development.
[513] J. Turkson,et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.
[514] T. Maniatis,et al. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter. , 1999, Molecular cell.
[515] J. Qin,et al. A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation. , 1999, Molecular cell.
[516] J. Kyriakis. Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family. , 1999, Gene expression.
[517] R. Sen,et al. A NF-kappa B/c-myc-dependent survival pathway is targeted by corticosteroids in immature thymocytes. , 1999, Journal of immunology.
[518] H. Gronemeyer,et al. Nuclear receptor coactivators as potential therapeutical targets: the HATs on the mouse trap , 1999 .
[519] T. Hofmann,et al. Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF‐κB‐dependent transcription , 1998, FEBS letters.
[520] I. Adcock,et al. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. , 1998, The Journal of clinical investigation.
[521] S. Nordeen,et al. Steroid-selective Initiation of Chromatin Remodeling and Transcriptional Activation of the Mouse Mammary Tumor Virus Promoter Is Controlled by the Site of Promoter Integration* , 1998, The Journal of Biological Chemistry.
[522] A. Harken,et al. INTERLEUKIN‐10 STABILIZES INHIBITORY kB-α IN HUMAN MONOCYTES , 1998 .
[523] M. Mann,et al. Identification of the receptor component of the IκBα–ubiquitin ligase , 1998, Nature.
[524] K. Kliche,et al. Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes. , 1998, Blood.
[525] L. Whitesell,et al. Molecular chaperones: biology and prospects for pharmacological intervention. , 1998, Pharmacological reviews.
[526] N. Engedal,et al. CREB Binding Protein Is a Coactivator for the Androgen Receptor and Mediates Cross-talk with AP-1* , 1998, The Journal of Biological Chemistry.
[527] G. Schütz,et al. Glucocorticoid signalling—multiple variations of a common theme , 1998, Molecular and Cellular Endocrinology.
[528] R. Tjian,et al. TAFII mutations disrupt Dorsal activation in the Drosophila embryo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[529] A. Livolsi,et al. Tumor Necrosis Factor-α Activation of Nuclear Transcription Factor-κB in Marrow Macrophages Is Mediated by c-Src Tyrosine Phosphorylation of IκBα* , 1998, The Journal of Biological Chemistry.
[530] A. Baldwin,et al. Activation of Nuclear Factor-κB-dependent Transcription by Tumor Necrosis Factor-α Is Mediated through Phosphorylation of RelA/p65 on Serine 529* , 1998, The Journal of Biological Chemistry.
[531] C. Glass,et al. Nuclear Integration of Glucocorticoid Receptor and Nuclear Factor-κB Signaling by CREB-binding Protein and Steroid Receptor Coactivator-1* , 1998, The Journal of Biological Chemistry.
[532] R J Fletterick,et al. Structure and specificity of nuclear receptor-coactivator interactions. , 1998, Genes & development.
[533] M. Rieder,et al. Multiplicity of glucocorticoid action in inhibiting allograft rejection. , 1998, Cell transplantation.
[534] R. Haché,et al. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor. , 1998, Molecular endocrinology.
[535] Nanxin Li,et al. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[536] P. Freemont,et al. Protein regulation: Tag wrestling with relatives of ubiquitin , 1998, Current Biology.
[537] A. Barthel,et al. Activation of Protein Kinase B/Akt Is Sufficient to Repress the Glucocorticoid and cAMP Induction of Phosphoenolpyruvate Carboxykinase Gene* , 1998, The Journal of Biological Chemistry.
[538] G. Adler,et al. Activation of NF?B in inflammatory bowel disease , 1998 .
[539] G. Krikun,et al. Chronic antagonism of nuclear factor-kappaB activity in cytotrophoblasts by dexamethasone: a potential mechanism for antiinflammatory action of glucocorticoids in human placenta. , 1998, The Journal of clinical endocrinology and metabolism.
[540] F. L. Moore,et al. Solubilization and pharmacological characterization of a glucocorticoid membrane receptor from an amphibian brain , 1998, The Journal of Steroid Biochemistry and Molecular Biology.
[541] N. Irani-Hakime,et al. The antiproliferative effect of glucocorticoids: is it related to induction of TGF-beta? , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[542] E. Zandi,et al. IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.
[543] P. Baeuerle,et al. IKAP is a scaffold protein of the IκB kinase complex , 1998, Nature.
[544] D. DeFranco,et al. The DNA-binding and tau2 transactivation domains of the rat glucocorticoid receptor constitute a nuclear matrix-targeting signal. , 1998, Molecular endocrinology.
[545] J. Harmon,et al. Glucocorticoid-Induced Apoptosis and Regulation of NF-κB Activity in Human Leukemic T Cells. , 1998, Endocrinology.
[546] R. Dikstein,et al. TAFII105 mediates activation of anti‐apoptotic genes by NF‐κB , 1998 .
[547] P. Herrlich,et al. Sequential DNA damage‐independent and ‐dependent activation of NF‐κB by UV , 1998 .
[548] James L. McGaugh,et al. Stress and glucocorticoids impair retrieval of long-term spatial memory , 1998, Nature.
[549] José Luis de la Pompa,et al. Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo , 1998, Cell.
[550] D. Alessi,et al. Mitogen‐ and stress‐activated protein kinase‐1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB , 1998, The EMBO journal.
[551] B. Lim,et al. IκB Is a Substrate for a Selective Pathway of Lysosomal Proteolysis , 1998 .
[552] R. Hay,et al. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. , 1998, Molecular cell.
[553] J. Reul,et al. Induction of cytokine receptors by glucocorticoids: functional and pathological significance. , 1998, Trends in pharmacological sciences.
[554] D. Reinberg,et al. NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. , 1998, Molecular cell.
[555] Hueng-Sik Choi,et al. Steroid Receptor Coactivator-1 Coactivates Activating Protein-1-mediated Transactivations through Interaction with the c-Jun and c-Fos Subunits* , 1998, The Journal of Biological Chemistry.
[556] R. Gaynor,et al. DNA-Dependent Protein Kinase Phosphorylation of IκBα and IκBβ Regulates NF-κB DNA Binding Properties , 1998, Molecular and Cellular Biology.
[557] A. Koj. Termination of acute-phase response: role of some cytokines and anti-inflammatory drugs. , 1998, General pharmacology.
[558] J. Baraban,et al. Inhibition versus induction of apoptosis by proteasome inhibitors depends on concentration , 1998, Cell Death and Differentiation.
[559] A. Hoffmann,et al. Suppression of Steady-state, but not Stimulus-induced NF-κB Activity Inhibits Alphavirus-induced Apoptosis , 1998, The Journal of cell biology.
[560] G. Courtois,et al. Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.
[561] M. Barrot,et al. Dopamine-dependent responses to morphine depend on glucocorticoid receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[562] M. Guenther,et al. Proteasomal regulation of nuclear receptor corepressor-mediated repression. , 1998, Genes & development.
[563] P. Barnes,et al. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. , 1998, Clinical science.
[564] H. Gronemeyer,et al. The nuclear receptor ligand-binding domain: structure and function. , 1998, Current opinion in cell biology.
[565] G. Nabel,et al. Modulation of cytokine‐induced HIV gene expression by competitive binding of transcription factors to the coactivator p300 , 1998, The EMBO journal.
[566] P. Herrlich,et al. Transcriptional cross-talk, the second mode of steroid hormone receptor action , 1998, Journal of Molecular Medicine.
[567] K. Kaestner,et al. DNA Binding of the Glucocorticoid Receptor Is Not Essential for Survival , 1998, Cell.
[568] I. Adcock,et al. Effect of dexamethasone on interleukin‐1β‐(IL‐1β)‐induced nuclear factor‐κB (NF‐κB) and κB‐dependent transcription in epithelial cells , 1998 .
[569] M. Karin. New Twists in Gene Regulation by Glucocorticoid Receptor: Is DNA Binding Dispensable? , 1998, Cell.
[570] T. Archer,et al. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex , 1998, Nature.
[571] G. Chrousos,et al. Mechanisms of Glucocorticoid‐Resistant Asthma a , 1998, Annals of the New York Academy of Sciences.
[572] F. Holsboer,et al. High Constitutive NFk B Activity Mediates Resistance to Oxidative Stress in Neuronal Cells , 1998 .
[573] Jeffrey A. Lefstin,et al. Allosteric effects of DNA on transcriptional regulators , 1998, Nature.
[574] J C Reed,et al. IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases , 1998, The EMBO journal.
[575] S. Ghosh,et al. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. , 1998, Molecular cell.
[576] J. Cidlowski,et al. Glucocorticoid receptor phosphorylation: Overview, function and cell cycle-dependence 1 1 Proceedings of the 13th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology “Recent Advances in Steroid Biochemistry & Molecular Biology” Monaco 25–28 May 1997. , 1998, The Journal of Steroid Biochemistry and Molecular Biology.
[577] M. Bagchi,et al. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. , 1998, Molecular endocrinology.
[578] J. Hampe,et al. Activation of nuclear factor κB in inflammatory bowel disease , 1998, Gut.
[579] J. Blenis,et al. pp90rsk1 Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167 , 1998, Molecular and Cellular Biology.
[580] J. Wang,et al. Further characterization of the glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene. The role of the glucocorticoid receptor-binding sites. , 1998, Molecular endocrinology.
[581] N. Bazan,et al. Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[582] B. O’Malley,et al. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. , 1998, Science.
[583] K.,et al. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[584] S. Logan,et al. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[585] O. Jänne,et al. CREB-binding protein in androgen receptor-mediated signaling. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[586] T. Archer,et al. Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter , 1998, The EMBO journal.
[587] A. Strasser,et al. B Lymphocytes Differentially Use the Rel and Nuclear Factor κB1 (NF-κB1) Transcription Factors to Regulate Cell Cycle Progression and Apoptosis in Quiescent and Mitogen-activated Cells , 1998, The Journal of experimental medicine.
[588] B. Burg,et al. A Dual Mechanism Mediates Repression of NF-κB Activity by Glucocorticoids , 1998 .
[589] N. Weigel,et al. The Nuclear Corepressors NCoR and SMRT Are Key Regulators of Both Ligand- and 8-Bromo-Cyclic AMP-Dependent Transcriptional Activity of the Human Progesterone Receptor , 1998, Molecular and Cellular Biology.
[590] D. Green,et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. , 1998, Molecular cell.
[591] G. Haegeman,et al. p38 and Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase Pathways Are Required for Nuclear Factor-κB p65 Transactivation Mediated by Tumor Necrosis Factor* , 1998, The Journal of Biological Chemistry.
[592] A. Stewart,et al. Different positioning of the ligand‐binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists , 1998, The EMBO journal.
[593] W. Sha. Regulation of Immune Responses by NF-κB/Rel Transcription Factors , 1998, The Journal of experimental medicine.
[594] S. Shumway,et al. Novel IκBα Proteolytic Pathway in WEHI231 Immature B Cells , 1998, Molecular and Cellular Biology.
[595] C. Thompson,et al. Human IAP-Like Protein Regulates Programmed Cell Death Downstream of Bcl-xL and Cytochrome c , 1998, Molecular and Cellular Biology.
[596] J. Cidlowski,et al. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. , 1998, Molecular endocrinology.
[597] H. Gronemeyer,et al. Therapeutic potential of selective modulators of nuclear receptor action. , 1998, Current opinion in chemical biology.
[598] M J May,et al. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.
[599] C. Lowenstein,et al. Involvement of transcriptional mechanisms in the inhibition of NOS2 expression by dexamethasone in rat mesangial cells. , 1998, Kidney international.
[600] G. Kroemer,et al. The mitochondrial death/life regulator in apoptosis and necrosis. , 1998, Annual review of physiology.
[601] A. Muñoz,et al. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. , 1997, Genes & development.
[602] W. Fiers,et al. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[603] T. Meyer,et al. A Weak TATA Box Is a Prerequisite for Glucocorticoid-dependent Repression of the Osteocalcin Gene* , 1997, The Journal of Biological Chemistry.
[604] J. Hagood,et al. STAT3 Acts as a Co-activator of Glucocorticoid Receptor Signaling* , 1997, The Journal of Biological Chemistry.
[605] N. Perkins. Achieving transcriptional specificity with nf-κb , 1997 .
[606] S. Tenbaum,et al. Nuclear receptors: structure, function and involvement in disease. , 1997, The international journal of biochemistry & cell biology.
[607] C. Riccardi,et al. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. , 1997, Immunity.
[608] N. Mackman,et al. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. , 1997, Journal of immunology.
[609] S. Fluharty,et al. Emerging mechanisms of the behavioral effects of steroids , 1997, Current Opinion in Neurobiology.
[610] T. Billiar,et al. Dexamethasone suppresses iNOS gene expression by upregulating I-κBα and inhibiting NF-κB. , 1997, American journal of physiology. Gastrointestinal and liver physiology.
[611] S. Farrow,et al. Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids. , 1997, The Biochemical journal.
[612] John Calvin Reed,et al. The c‐IAP‐1 and c‐IAP‐2 proteins are direct inhibitors of specific caspases , 1997, The EMBO journal.
[613] H. Horvitz,et al. Phosphorylation of IκB-α Inhibits Its Cleavage by Caspase CPP32 in Vitro * , 1997, The Journal of Biological Chemistry.
[614] J. Martial,et al. The glucocorticoid receptor inhibits the human prolactin gene expression by interference with Pit-1 activity , 1997, Molecular and Cellular Endocrinology.
[615] P. Andrew,et al. 1α,25-Dihydroxyvitamin D3 and a Variety of its Natural Metabolites Transcriptionally Repress Nuclear-Factor-κB-Mediated Interleukin-8 Gene Expression , 1997 .
[616] J. Swantek,et al. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK , 1997, Molecular and cellular biology.
[617] K. Kliche,et al. Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes. , 1997, Blood.
[618] J. Carlstedt-Duke,et al. Evidence That the β-Isoform of the Human Glucocorticoid Receptor Does Not Act as a Physiologically Significant Repressor* , 1997, The Journal of Biological Chemistry.
[619] Zbigniew Dauter,et al. Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.
[620] B. Huber,et al. Cytokine rescue from glucocorticoid induced apoptosis in T cells is mediated through inhibition of IκBα , 1997 .
[621] J. Drouin,et al. Antagonism between Nur77 and glucocorticoid receptor for control of transcription , 1997, Molecular and cellular biology.
[622] C. Allis,et al. Steroid receptor coactivator-1 is a histone acetyltransferase , 1997, Nature.
[623] T. Wilckens,et al. Glucocorticoids and immune function: unknown dimensions and new frontiers. , 1997, Immunology today.
[624] E. Kalkhoven,et al. Distinct Domains of the RelA NF-κB Subunit Are Required for Negative Cross-talk and Direct Interaction with the Glucocorticoid Receptor* , 1997, The Journal of Biological Chemistry.
[625] F. Delaunay,et al. A New Function for the C-terminal Zinc Finger of the Glucocorticoid Receptor , 1997, The Journal of Biological Chemistry.
[626] W. Pratt,et al. Folding of the Glucocorticoid Receptor by the Heat Shock Protein (hsp) 90-based Chaperone Machinery , 1997, The Journal of Biological Chemistry.
[627] P. Herrlich,et al. IκBα‐independent downregulation of NF‐κB activity by glucocorticoid receptor , 1997, The EMBO journal.
[628] J. Gustafsson,et al. Glucocorticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box. , 1997, DNA and cell biology.
[629] H. Gronemeyer,et al. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. , 1997, Molecular endocrinology.
[630] M. Handel. Transcription factors AP-1 and NF-κB: Where steroids meet the gold standard of anti-rheumatic drugs , 1997, Inflammation Research.
[631] K. Yamamoto,et al. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor , 1997, Molecular and cellular biology.
[632] Guy S. Salvesen,et al. X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.
[633] G. Chrousos,et al. Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants. , 1997, Molecular endocrinology.
[634] M. Galigniana,et al. Protein Phosphatase 5 Is a Major Component of Glucocorticoid Receptor·hsp90 Complexes with Properties of an FK506-binding Immunophilin* , 1997, The Journal of Biological Chemistry.
[635] C. Kaltschmidt,et al. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. , 1997, The Journal of clinical investigation.
[636] A. Ray,et al. Repression of interleukin‐6 gene expression by 17β‐estradiol: , 1997 .
[637] K. Horwitz,et al. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. , 1997, Molecular endocrinology.
[638] W. Pratt,et al. Steroid receptor interactions with heat shock protein and immunophilin chaperones. , 1997, Endocrine reviews.
[639] T. Garcia,et al. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. , 1997, Nucleic acids research.
[640] Jian Wang,et al. Androgen and Glucocorticoid Receptor Heterodimer Formation , 1997, The Journal of Biological Chemistry.
[641] J. Workman,et al. SWI/SNF Stimulates the Formation of Disparate Activator-Nucleosome Complexes but Is Partially Redundant with Cooperative Binding* , 1997, The Journal of Biological Chemistry.
[642] S. Schreiber,et al. Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase , 1997, Cell.
[643] P. Eriksson,et al. The role of chromatin in transcriptional regulation. , 1997, The international journal of biochemistry & cell biology.
[644] K. Ray,et al. Glucocorticoid inhibition of cytokine-induced E-selectin promoter activation. , 1997, Biochemical Society Transactions.
[645] A. Wolffe,et al. Activators and repressors: making use of chromatin to regulate transcription , 1997, Genes to cells : devoted to molecular & cellular mechanisms.
[646] C. Glass,et al. A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression , 1997, nature.
[647] J. Anrather,et al. Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun. , 1997, Journal of immunology.
[648] J. Cidlowski,et al. Mouse Glucocorticoid Receptor Phosphorylation Status Influences Multiple Functions of the Receptor Protein* , 1997, The Journal of Biological Chemistry.
[649] R. Jope,et al. Dexamethasone attenuates NF-κ B DNA binding activity without inducing I κ B levels in rat brain in vivo , 1997 .
[650] M. Gerritsen,et al. CREB-binding protein/p300 are transcriptional coactivators of p65. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[651] E. Zandi,et al. AP-1 function and regulation. , 1997, Current opinion in cell biology.
[652] P. Chambon,et al. Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2. , 1997, Gene.
[653] A. Munck,et al. Control by basal phosphorylation of cell cycle-dependent, hormone-induced glucocorticoid receptor hyperphosphorylation. , 1997, Molecular endocrinology.
[654] M. Schmitz,et al. Basal transcription factors TBP and TFIIB and the viral coactivator E1A 13S bind with distinct affinities and kinetics to the transactivation domain of NF-kappaB p65. , 1997, Nucleic acids research.
[655] J. Gustafsson,et al. Mechanism of gene expression by the glucocorticoid receptor: Role of protein‐protein interactions , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.
[656] S. Okret,et al. Studies on the mechanism of glucocorticoid-mediated repression from a negative glucocorticoid response element from the bovine prolactin gene. , 1997, DNA and cell biology.
[657] O. Wrange,et al. Glucocorticoid receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI/SNF complex , 1997, Molecular and cellular biology.
[658] O. Jänne,et al. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription. , 1997, Molecular endocrinology.
[659] S. Akira,et al. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor , 1997, The Journal of Steroid Biochemistry and Molecular Biology.
[660] P. Baeuerle,et al. NF-?B as a Frequent Target for Immunosuppressive and , 1997 .
[661] G. Jenster,et al. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. , 1997, Recent progress in hormone research.
[662] H. Erdjument-Bromage,et al. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. , 1997, Cell.
[663] P. Baeuerle,et al. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. , 1997, Advances in immunology.
[664] B. Osborne,et al. Gene regulation associated with apoptosis. , 1997, Critical reviews in eukaryotic gene expression.
[665] F. Holsboer,et al. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. , 1997, Endocrinology.
[666] J. Funder. Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. , 1997, Annual review of medicine.
[667] E. Falkenstein,et al. Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. , 1996, Biochemical and biophysical research communications.
[668] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[669] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[670] M. Rieder,et al. Regulation of cytokine and cytokine receptor expression by glucocorticoids , 1996, Journal of leukocyte biology.
[671] N. Weigel. Steroid hormone receptors and their regulation by phosphorylation. , 1996, The Biochemical journal.
[672] Michael Karin,et al. Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.
[673] Chawnshang Chang,et al. Inhibition of NFκB Activity through Maintenance of IκBα Levels Contributes to Dihydrotestosterone-mediated Repression of the Interleukin-6 Promoter* , 1996, The Journal of Biological Chemistry.
[674] David Baltimore,et al. NF-κB: Ten Years After , 1996, Cell.
[675] F. Sackey,et al. Determinants of subcellular distribution of the glucocorticoid receptor. , 1996, Molecular endocrinology.
[676] K. Horwitz,et al. Nuclear receptor coactivators and corepressors. , 1996, Molecular endocrinology.
[677] T. Ikonen,et al. Mutual Transcriptional Interference between RelA and Androgen Receptor* , 1996, The Journal of Biological Chemistry.
[678] F. Santini,et al. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. , 1996, Journal of immunology.
[679] C. Mueller-Dieckmann,et al. Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α , 1996, Cell.
[680] D. White,et al. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins. , 1996, Oncogene.
[681] H. Watanabe,et al. Regulation of neutrophil apoptosis--its biological significance in inflammation and the immune response. , 1996, Human cell.
[682] G. Crabtree,et al. Diversity and specialization of mammalian SWI/SNF complexes. , 1996, Genes & development.
[683] L. Pei. Identification of a negative glucocorticoid response element in the rat type 1 vasoactive intestinal polypeptide receptor gene. , 1996, The Journal of biological chemistry.
[684] A. Ristimäki,et al. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. , 1996, The Biochemical journal.
[685] F. Bach,et al. Glucocorticoid-mediated Repression of NFκB Activity in Endothelial Cells Does Not Involve Induction of IκBα Synthesis* , 1996, The Journal of Biological Chemistry.
[686] M. Karin,et al. Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. , 1996, American journal of respiratory and critical care medicine.
[687] L. Chaudhary,et al. Regulation of Interleukin-8 Gene Expression by Interleukin-1β, Osteotropic Hormones, and Protein Kinase Inhibitors in Normal Human Bone Marrow Stromal Cells* , 1996, The Journal of Biological Chemistry.
[688] M. Arsura,et al. TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBα , 1996 .
[689] G. Chrousos,et al. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. , 1996, Endocrine reviews.
[690] Thorsten Heinzel,et al. A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.
[691] A. Cato,et al. Molecular mechanisms of anti‐inflammatory action of glucocorticoids , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.
[692] D. DeFranco,et al. ATP-dependent release of glucocorticoid receptors from the nuclear matrix , 1996, Molecular and cellular biology.
[693] F. Holsboer,et al. Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action. , 1996, Trends in pharmacological sciences.
[694] W. Fiers,et al. The p38/RK mitogen‐activated protein kinase pathway regulates interleukin‐6 synthesis response to tumor necrosis factor. , 1996, The EMBO journal.
[695] E. Kalkhoven,et al. Negative Interaction between the RelA(p65) Subunit of NF-B and the Progesterone Receptor (*) , 1996, The Journal of Biological Chemistry.
[696] M. Karin. The regulation of AP-1 activity by mitogen-activated protein kinases. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[697] T. Lee,et al. Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma. , 1996, American journal of respiratory and critical care medicine.
[698] B. Katzenellenbogen,et al. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. , 1996, Molecular endocrinology.
[699] M. Beato,et al. Interaction of steroid hormone receptors with transcription factors involves chromatin remodelling , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[700] Kazuyoshi Watanabe,et al. Glucocorticoid-mediated Gene Suppression of Rat Cytokine-induced Neutrophil Chemoattractant CINC/gro, a Member of the Interleukin-8 Family, through Impairment of NF-B Activation (*) , 1996, The Journal of Biological Chemistry.
[701] D. Wakefield,et al. Modulation of endothelial cell expression of ICAM-1, E-selectin, and VCAM-1 by beta-estradiol, progesterone, and dexamethasone. , 1996, Cellular immunology.
[702] D. Garrel. Corticosteroid-binding globulin during inflammation and burn injury: nutritional modulation and clinical implications. , 1996, Hormone research.
[703] H. Maeda,et al. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. , 1996, Journal of immunology.
[704] U. Förstermann,et al. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B. , 1996, Molecular pharmacology.
[705] Andrew J. Bannister,et al. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. , 1995, Oncogene.
[706] Miguel Beato,et al. Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.
[707] D. Baltimore,et al. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. , 1995, Genes & development.
[708] Joseph A. DiDonato,et al. Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.
[709] A. Baldwin,et al. Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.
[710] B Stein,et al. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta , 1995, Molecular and cellular biology.
[711] O. Wrange,et al. Accessibility of a glucocorticoid response element in a nucleosome depends on its rotational positioning , 1995, Molecular and cellular biology.
[712] O. Jänne,et al. Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. , 1995, Molecular endocrinology.
[713] David Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.
[714] I. Adcock,et al. Steroid resistance in asthma. , 1995, QJM : monthly journal of the Association of Physicians.
[715] T. Wilckens. Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction. , 1995, Trends in pharmacological sciences.
[716] G. Chrousos,et al. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. , 1995, The Journal of clinical investigation.
[717] A. Sica,et al. Negative Transcriptional Regulation of the Interferon-γ Promoter by Glucocorticoids and Dominant Negative Mutants of c-Jun (*) , 1995, The Journal of Biological Chemistry.
[718] K. Yamamoto,et al. LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[719] C. Ware,et al. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids , 1995, The Journal of experimental medicine.
[720] J. Gustafsson,et al. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. , 1995, Molecular endocrinology.
[721] M. Meisterernst,et al. Interaction of the COOH-terminal Transactivation Domain of p65 NF-κB with TATA-binding Protein, Transcription Factor IIB, and Coactivators (*) , 1995, The Journal of Biological Chemistry.
[722] P. Chambon,et al. RAR‐specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage‐independent cell proliferation. , 1995, The EMBO journal.
[723] E. Canalis,et al. Cortisol downregulates osteoblast α1(I) procollagen mRNA by transcriptional and posttranscriptional mechanisms , 1995 .
[724] S. Ju,et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation , 1995, Nature.
[725] P. Krammer,et al. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) , 1995, Nature.
[726] M. Karin,et al. Glucocorticoid‐induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. , 1995, The EMBO journal.
[727] J. Cidlowski,et al. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors , 1995, Molecular and cellular biology.
[728] D. Linzer,et al. Role of the composite glucocorticoid response element in proliferin gene expression. , 1995, Gene Expression.
[729] H. Gronemeyer,et al. Transcription factors 3: nuclear receptors. , 1995, Protein profile.
[730] T. Schall,et al. Induction of chemokine gene expression by major histocompatibility complex class II ligands in human fibroblast-like synoviocytes. Differential regulation by interleukin-4 and dexamethasone. , 1994, The Journal of biological chemistry.
[731] A. C. Webb,et al. Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1 beta gene , 1994, Molecular and cellular biology.
[732] M. Wehling. Nongenomic actions of steroid hormones , 1994, Trends in Endocrinology & Metabolism.
[733] P. Herrlich,et al. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP‐1. , 1994, The EMBO journal.
[734] M. Tsuda,et al. Modulation of AP‐1 activity by nitric oxide (NO) in vitro: NO‐mediated modulation of AP‐1 , 1994, FEBS letters.
[735] M. Karin,et al. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor , 1994, Nature.
[736] K. Matsushima,et al. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. , 1994, The Journal of biological chemistry.
[737] A. Ray,et al. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. , 1994, The Journal of biological chemistry.
[738] A. Ray,et al. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[739] K. Decker,et al. Regulation of the mRNA expression for tumor necrosis factor-α in rat liver macrophages , 1994 .
[740] Naofumi MukaidaSg,et al. Novel Mechanism of Glucocorticoid-mediated Gene Repression , 1994 .
[741] D. Boumpas,et al. Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates , 1993, Annals of Internal Medicine.
[742] O. Wrange,et al. Translational positioning of a nucleosomal glucocorticoid response element modulates glucocorticoid receptor affinity. , 1993, Genes & development.
[743] H. Herschman,et al. “Macrophage” nitric oxide synthase is a glucocorticoid‐inhibitable primary response gene in 3T3 cells , 1993, Journal of cellular physiology.
[744] B. O’Malley,et al. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. , 1993, Molecular endocrinology.
[745] S. Bourgeois,et al. Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. , 1993, Molecular endocrinology.
[746] S. Najjar,et al. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. , 1993, The Journal of clinical investigation.
[747] L. Koenderman,et al. Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. , 1993, American journal of respiratory cell and molecular biology.
[748] S. Akira,et al. A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction , 1993, Molecular and cellular biology.
[749] K. Yamamoto,et al. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. , 1993, Science.
[750] C. Lowenstein,et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[751] M. Parker. Steroid hormone action , 1993 .
[752] I. Herskowitz,et al. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. , 1992, Science.
[753] K. Yamamoto,et al. The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. , 1992, Genes & development.
[754] G. Weissmann,et al. A Mechanism for the Antiinflammatory Effects of Corticosteroids , 1993, Journal of Pediatric Gastroenterology and Nutrition.
[755] K. Umesono,et al. Modulation of glucocorticoid receptor function by protein kinase A. , 1992, Molecular endocrinology.
[756] B. Huber,et al. IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. , 1992, Journal of immunology.
[757] P. Mellon,et al. Mutual cross-interference between glucocorticoid receptor and CREB inhibits transactivation in placental cells. , 1992, The New biologist.
[758] I. Screpanti,et al. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements , 1992, The Journal of experimental medicine.
[759] A. Munck,et al. Phosphorylation of steroid hormone receptors. , 1992, Endocrine reviews.
[760] M. Fey,et al. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. , 1992, Blood.
[761] H. Gronemeyer,et al. Cell‐specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. , 1991, The EMBO journal.
[762] S. Jimenez,et al. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. , 1991, The Journal of clinical investigation.
[763] J. Azizkhan,et al. Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts , 1991, Molecular and cellular biology.
[764] M. Garabedian,et al. Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. , 1991, Molecular endocrinology.
[765] A. Ray,et al. Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: is direct DNA binding necessary? , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[766] D. Pasko,et al. Size and steroid-binding characterization of membrane-associated glucocorticoid receptor in S-49 lymphoma cells , 1991, Steroids.
[767] C. Watson,et al. Studies on the arrangement of glucocorticoid receptors in the plasma membrane of S-49 lymphoma cells , 1991, Steroids.
[768] F. L. Moore,et al. A corticosteroid receptor in neuronal membranes. , 1991, Science.
[769] J. Chiu,et al. Regulation of alpha-fetoprotein gene expression by antagonism between AP-1 and the glucocorticoid receptor at their overlapping binding site. , 1991, The Journal of biological chemistry.
[770] J. Gustafsson,et al. Identification of protein contact sites within the glucocorticoid/progestin response element. , 1991, Molecular endocrinology.
[771] H. Baumann,et al. Interaction of cytokine- and glucocorticoid-response elements of acute-phase plasma protein genes. Importance of glucocorticoid receptor level and cell type for regulation of the elements from rat alpha 1-acid glycoprotein and beta-fibrinogen genes. , 1990, The Journal of biological chemistry.
[772] M. Merćep,et al. Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. , 1990, Journal of immunology.
[773] S. Moncada,et al. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[774] D. Ron,et al. Synergistic enhansons located within an acute phase responsive enhancer modulate glucocorticoid induction of angiotensinogen gene transcription. , 1990, Molecular endocrinology.
[775] M. Karin,et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.
[776] Stephan Gebel,et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone , 1990, Cell.
[777] S. Kliewer,et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor , 1990, Cell.
[778] K. Yamamoto,et al. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. , 1990, Science.
[779] D. Ron,et al. The permissive role of glucocorticoids on interleukin-1 stimulation of angiotensinogen gene transcription is mediated by an interaction between inducible enhancers. , 1990, Molecular and cellular biology.
[780] P. Baeuerle,et al. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B , 1990, Molecular and cellular biology.
[781] P. Baeuerle,et al. Regulation ofTumorNecrosis Factor AlphaTranscription in Macrophages: Involvement ofFourKB-Like Motifs andof Constitutive andInducible FormsofNF-KB , 1990 .
[782] J. Motin,et al. Decreased immunoreactivity and binding activity of corticosteroid-binding globulin in serum in septic shock. , 1989, Clinical chemistry.
[783] G. Chalepakis,et al. Gene regulation by steroid hormones. , 1989, Cell.
[784] R. Evans,et al. Transcriptional inhibition by a glucocorticoid receptor-β-galactosidase fusion protein , 1988, Cell.
[785] B. O’Malley,et al. A steroid response element can function in the absence of a distal promoter. , 1988, Molecular endocrinology.
[786] L. Poellinger,et al. Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms. , 1988, Molecular endocrinology.
[787] J D Baxter,et al. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. , 1988, Science.
[788] J. Gustafsson,et al. Down-regulation of glucocorticoid receptor mRNA by glucocorticoid hormones and recognition by the receptor of a specific binding sequence within a receptor cDNA clone. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[789] R. W. Kuhn,et al. The serum transport of steroid hormones. , 1982, Recent progress in hormone research.
[790] R. Harrison,et al. Heterogeneity of AtT-20 cell glucocorticoid binding sites: evidence for a membrane receptor. , 1979, Advances in experimental medicine and biology.
[791] S. J. Higgins,et al. General presence of glucocorticoid receptors in mammalian tissues. , 1974, Endocrinology.
[792] Z. Trzcínska-Dabrowska. [Corticosteroids in ophthalmology]. , 1972, Polski tygodnik lekarski.